Abstract:Activation of the p53 tumor suppressor can lead to cell cycle arrest. The key mechanism of p53-mediated arrest is transcriptional downregulation of many cell cycle genes. In recent years it has become evident that p53-dependent repression is controlled by the p53–p21–DREAM–E2F/CHR pathway (p53–DREAM pathway). DREAM is a transcriptional repressor that binds to E2F or CHR promoter sites. Gene regulation and deregulation by DREAM shares many mechanistic characteristics with the retinoblastoma pRB tumor suppressor that acts through E2F elements. However, because of its binding to E2F and CHR elements, DREAM regulates a larger set of target genes leading to regulatory functions distinct from pRB/E2F. The p53–DREAM pathway controls more than 250 mostly cell cycle-associated genes. The functional spectrum of these pathway targets spans from the G1 phase to the end of mitosis. Consequently, through downregulating the expression of gene products which are essential for progression through the cell cycle, the p53–DREAM pathway participates in the control of all checkpoints from DNA synthesis to cytokinesis including G1/S, G2/M and spindle assembly checkpoints. Therefore, defects in the p53–DREAM pathway contribute to a general loss of checkpoint control. Furthermore, deregulation of DREAM target genes promotes chromosomal instability and aneuploidy of cancer cells. Also, DREAM regulation is abrogated by the human papilloma virus HPV E7 protein linking the p53–DREAM pathway to carcinogenesis by HPV. Another feature of the pathway is that it downregulates many genes involved in DNA repair and telomere maintenance as well as Fanconi anemia. Importantly, when DREAM function is lost, CDK inhibitor drugs employed in cancer treatment such as Palbociclib, Abemaciclib and Ribociclib can compensate for defects in early steps in the pathway upstream from cyclin/CDK complexes. In summary, the p53–p21–DREAM–E2F/CHR pathway controls a plethora of cell cycle genes, can contribute to cell cycle arrest and is a target for cancer therapy.

RB, p130 and p107 differentially repress G1/S and G2/M genes after p53 activation

P130/p107/p105rb-Dependent Transcriptional Repression During DNA-damage-induced Cell-Cycle Exit at G2

Cell cycle regulation: p53-p21-RB signaling

Δ113p53/Δ133p53 Converts P53 from a Repressor to a Promoter of DNA Double-Stand Break Repair.

Evolutionarily Conserved Multisubunit RBL2/p130 and E2F4 Protein Complex Represses Human Cell Cycle-Dependent Genes in Quiescence.

Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM

Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex

Role of Retinoblastoma Gene Product in P53-Mediated DNA Damage Response

p53-dependent gene repression through p21 is mediated by recruitment of E2F4 repression complexes

B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells

Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16

Retinoblastoma tumor suppressor protein–dependent methylation of histone H3 lysine 27 is associated with irreversible cell cycle exit

Ki-67 gene expression

Ribonucleotide reductase small subunit p53R2 translocates in cell cycle and plays an essential role for DNA replication

RB AND P130 CONTROL THE POST-MITOTIC PHENOTYPE IN ADULT HEART MUSCLE BY RECRUITING THE HETEROCHROMATIN PROMOTING FACTOR HP1γ TO GROWTH ASSOCIATED GENES

Interactions Between P53 And Mdm2 In A Mammalian-Cell Cycle Checkpoint Pathway

The Retinoblastoma Gene Product Regulates Progression Through the G1 Phase of the Cell Cycle

Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks

Krüppel-like Factor 4 Mediates P53-Dependent G1/S Cell Cycle Arrest in Response to DNA Damage

Active Transcriptional Repression by the Rb–E2F Complex Mediates G1 Arrest Triggered by P16ink4a, TGFβ, and Contact Inhibition

HDAC activity is dispensable for repression of cell-cycle genes by DREAM and E2F:RB complexes